Wordt geladen...
FGF23 from bench to bedside
There is a strong association between elevated circulating fibroblast growth factor-23 (FGF23) levels and adverse outcomes in patients with chronic kidney disease (CKD) of all stages. Initially discovered as a regulator of phosphate and vitamin D homeostasis, FGF23 has now been implicated in several...
Bewaard in:
| Gepubliceerd in: | Am J Physiol Renal Physiol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Physiological Society
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425620/ https://ncbi.nlm.nih.gov/pubmed/26864938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00606.2015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|